Enteris gets into contract manufacturing with new plant

Enteris BioPharma is looking to make some money on the side of its drug-delivery operation, opening a contract manufacturing facility and scouting for clients. The company has set aside space in its 32,000-square-foot plant in Boonton, NJ, for commercial API production, a move CEO Brian Zietsman said "is an important milestone for Enteris as we seek to fully maximize the assets and expertise that we acquired when the company was launched in 2013." More

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

The CRO will transfer most of its Pennsylvania-based biologics laboratory functions to a new, 73,000-square-foot site on Devon Park in Wayne.

Monoclonal antibodies developer Xencor extended a strategic alliance formed in 2016 with Selexis with four commercial license agreements.